NET PROFIT (x1000 SEK)
EMPLOYEES
ERCO Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-3,020
|
-4,970
|
-3,397 |
EBITDA |
-2,983
|
-4,933
|
-3,175 |
Total assets |
111
|
1,150
|
267 |
Current assets |
111
|
1,113
|
193 |
Current liabilities |
56
|
1,098
|
215 |
Equity capital |
55
|
52
![]() |
52 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
2
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
49.5%
|
4.5%
|
19.5% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-2720.7%
|
-432.2%
|
-1272.3% |
Current ratio |
198.2%
|
101.4%
|
89.8% |
Return on equity (ROE) |
-5490.9%
|
-9557.7%
|
-6532.7% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.